ダウンロード数 : ?
言語
英語
著者
Rahman Mohammed Tanjimur Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan
Rahman Munmun Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan
Katagiri Hiroshi Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan
Katagiri Atsuko Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan
Nakayama Naomi Department of Biocehmistory, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan
Ishikawa Noriyuki Department of Organ Pathology, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan
Miyazaki Kohji Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan
主題
type II ovarian carcinoma; KRAS; MAPK1; gene amplification; survival; MEK inhibitor
掲載誌名
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
14
7
開始ページ
13748
終了ページ
13762
ISSN
1422-0067
発行日
2013-07
DOI
PubMed ID
出版者
MDPI AG
資料タイプ
学術雑誌論文
部局
医学部
備考
This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.